OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study
Stock Information for OpGen Inc.
Loading
Please wait while we load your information from QuoteMedia.